EDGAR Filing Documents for 0001213900-18-008083

Form 1-A/A - Offering Statement [Regulation A]: [Amend]

SEC Accession No. 0001213900-18-008083

Filing Date

2018-06-22

Accepted

2018-06-22 17:09:51

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	1-A/A
1		primary_doc.xml	1-A/A	19576
2	PRELIMINARY OFFERING CIRCULAR	f1a2018a1_2020genesystems.htm	PART II AND III	942144
3	ENGAGEMENT AGREEMENT, EFFECTIVE APRIL 16, 2018, BETWEEN 20/20 GENESYSTEMS, INC.	f1a2018a1ex1_2020gene.htm	EX1A-1 UNDR AGMT	94853
4	FORM OF SECOND AMENDED AND RESTATED ARTICLES OF INCORPORATION OF 20/20 GENESYSTE	f1a2018a1ex2-1_2020gene.htm	EX1A-2A CHARTER	98717
5	FORM OF SUBSCRIPTION AGREEMENT	f1a2018a1ex4_2020gene.htm	EX1A-4 SUBS AGMT	63632
6	FORM OF ESCROW AGREEMENT	f1a2018a1ex6-1_2020gene.htm	EX1A-6 MAT CTRCT	109091
7	OPTION AGREEMENT TO LICENSE AND COMMERCIALIZE PAN-CANCER TEST ALGORITHM, DATED A	f1a2018a1ex6-2_2020gene.htm	EX1A-6 MAT CTRCT	121966
8	AMENDMENT TO OPTION AGREEMENT TO LICENSE AND COMMERCIALIZE PAN-CANCER TEST ALGOR	f1a2018a1ex6-3_2020gene.htm	EX1A-6 MAT CTRCT	16608
9	CANCER EARLY DETECTION ALGORITHM DEVELOPMENT COLLABORATION AGREEMENT, DATED FEBR	f1a2018a1ex6-4_2020gene.htm	EX1A-6 MAT CTRCT	51033
10	CONSENT OF DBBMCKENNON	f1a2018a1ex11-1_2020gene.htm	EX1A-11 CONSENT	2050
11	GRAPHIC	img_01.jpg	GRAPHIC	28636
12	GRAPHIC	img_02.jpg	GRAPHIC	29950
13	GRAPHIC	img_03.jpg	GRAPHIC	17497
14	GRAPHIC	img_04.jpg	GRAPHIC	64440
15	GRAPHIC	img_05.jpg	GRAPHIC	70140
16	GRAPHIC	img_06.jpg	GRAPHIC	35016
17	GRAPHIC	ex1_001.jpg	GRAPHIC	7276
	Complete submission text file	0001213900-18-008083.txt		1870153

Mailing Address 9430 KEY WEST AVE. ROCKVILLE MD 20850

Business Address 9430 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 2404536339

20/20 GeneSystems, Inc. (Filer) CIK: 0001139685 (see all company filings)